Monday, August 31, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Business

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

Forbes ·
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

Read the full article on Forbes ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.

More from Forbes

See all ›

More in Business

See all ›